Evozyne stock

Evozyne Stock

Operations, Productivity And Communication
Founded: 2020Funding to Date: $109Mhttps://www.evozyne.com

Evozyne operates a data-driven platform focused on evolution-based molecular engineering to design innovative proteins with enhanced capabilities. Their platform provides reliable models and insights into the physics of protein folding, function, and the evolutionary potential of synthetic drugs. This allows the healthcare industry to obtain tailored molecules that address specific challenges related to human health and bodily functions.

Investors Include:

Nvidia, OrbiMed, nVentures, Fidelity Investments, Valor Equity Partners, Paragon Biosciences, NVentures (Santa Clara).

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Unlock My Liquidity